Literature DB >> 22914915

[Specific spondylitis].

V Bullmann1, U R Liljenqvist, M Koriller, T Lange.   

Abstract

Tuberculosis of the spine usually occurs with a latency period after primary infection with tuberculosis (TB) and the most frequent agent is Mycobacterium tuberculosis. The rate of TB has increased due to the impact of acquired immunodeficiency syndrome (AIDS) and more than 50% of skeletal tuberculosis is localized in the spine. Spinal tuberculosis was discovered by Pott in 1776. Magnetic resonance imaging (MRI) with gadolineum is the most sensitive imaging method. Diagnostic accuracy is given by direct detection of Mycobacterium tuberculosis by punction or biopsy. Granuloma of the spine can lead to abscesses, severe spinal deformity with instability and potentially paraplegia. Chemotherapy is effective with a minimum duration of 6-12 months. In cases with neurological deficits and severe deformity there is an additional indication for surgical therapy. In the acute phase a posterior instrumentation, anterior debridement and reconstruction of the defect is indicated. After recovery of the spinal tuberculosis Pott's kyphosis could remain and operative correction can be managed by pedicle substraction osteotomy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22914915     DOI: 10.1007/s00132-012-1921-z

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  15 in total

Review 1.  Tuberculosis of the spine. Controversies and a new challenge.

Authors:  M S Moon
Journal:  Spine (Phila Pa 1976)       Date:  1997-08-01       Impact factor: 3.468

Review 2.  MRI characteristics of tuberculous spondylitis.

Authors:  S Currie; S Galea-Soler; D Barron; M Chandramohan; C Groves
Journal:  Clin Radiol       Date:  2011-05-12       Impact factor: 2.350

3.  Spinal tuberculosis: magnetic resonance imaging and neurological impairment.

Authors:  Robert Dunn; Ian Zondagh; Sally Candy
Journal:  Spine (Phila Pa 1976)       Date:  2011-03-15       Impact factor: 3.468

4.  Results of nonsurgical treatment of thoracic spinal tuberculosis in adults.

Authors:  Abhay Nene; Shekhar Bhojraj
Journal:  Spine J       Date:  2005 Jan-Feb       Impact factor: 4.166

Review 5.  Tuberculosis of the spine. A systematic review of case series.

Authors:  Manuel Fuentes Ferrer; Luisa Gutiérrez Torres; Oscar Ayala Ramírez; Mercedes Rumayor Zarzuelo; Náyade del Prado González
Journal:  Int Orthop       Date:  2011-11-25       Impact factor: 3.075

6.  [Surgical therapy of unspecific and specific Spondylodiscitis].

Authors:  T Lerner; L Hackenberg; S Rösler; U Joosten; H Halm; U Liljenqvist
Journal:  Z Orthop Ihre Grenzgeb       Date:  2005 Mar-Apr

Review 7.  General principles of osteoarticular tuberculosis.

Authors:  S M Tuli
Journal:  Clin Orthop Relat Res       Date:  2002-05       Impact factor: 4.176

8.  Infections of the spine in patients with human immunodeficiency virus.

Authors:  Marc A Weinstein; Frank J Eismont
Journal:  J Bone Joint Surg Am       Date:  2005-03       Impact factor: 5.284

9.  A controlled trial of ambulant out-patient treatment and in-patient rest in bed in the management of tuberculosis of the spine in young Korean patients on standard chemotherapy a study in Masan, Korea. First report of the Medical Research Council Working Party on Tuberculosis of the Spine.

Authors: 
Journal:  J Bone Joint Surg Br       Date:  1973-11

10.  A 10-year assessment of controlled trials of inpatient and outpatient treatment and of plaster-of-Paris jackets for tuberculosis of the spine in children on standard chemotherapy. Studies in Masan and Pusan, Korea. Ninth report of the Medical Research Council Working Party on Tuberculosis of the Spine.

Authors: 
Journal:  J Bone Joint Surg Br       Date:  1985-01
View more
  1 in total

1.  Utilization of ring-shaped bone allograft for surgical treatment of adolescent post-tubercular kyphosis: A retrospective study.

Authors:  Xiang Yin; Peng Liu; Yao-Yao Liu; Wei-Li Fan; Bai-Yi Liu; Jian-Hua Zhao
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.